Tikun Olam Cannbit Pharmaceuticals Ltd Cash Flow Conversion Efficiency
Tikun Olam Cannbit Pharmaceuticals Ltd cash flow conversion efficiency. Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has a cash flow conversion efficiency ratio of -0.082x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-4.35 Million ≈ $-11.66K USD) by net assets (ILA53.22 Million ≈ $142.69K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
Cash flow conversion efficiency of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024. This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Tikun Olam Cannbit Pharmaceuticals Ltd stock price today for real-time trading data and today's change.
Tikun Olam Cannbit Pharmaceuticals Ltd Cash Flow Conversion Ratio Explained
Tikun Olam Cannbit Pharmaceuticals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tikun Olam Cannbit Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Also see TKUN market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nova EYE Medical Ltd
AU:EYE
|
-0.059x |
|
Juic International
TWO:6114
|
0.032x |
|
Microbix Biosystems Inc.
TO:MBX
|
-0.019x |
|
Bangkok Sheet Metal Public Company Limited
BK:BM
|
0.047x |
|
Pico (Thailand) Public Company Limited
BK:PICO
|
-0.070x |
|
Aquaron Acquisition Corp. Common Stock
NASDAQ:AQU
|
-0.032x |
|
Xbrane Biopharma AB
ST:XBRANE
|
-0.009x |
|
Centric Holdings S.A
AT:CENTR
|
0.008x |
Annual Cash Flow Conversion Efficiency for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
The table below shows the annual cash flow conversion efficiency of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024. Review TKUN free cash flow debt coverage to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA-5.35 Million ≈ $-14.34K |
ILA-3.77 Million ≈ $-10.11K |
0.705x | +870.69% |
| 2023-12-31 | ILA33.04 Million ≈ $88.59K |
ILA-3.02 Million ≈ $-8.11K |
-0.092x | +41.26% |
| 2022-12-31 | ILA116.92 Million ≈ $313.46K |
ILA-18.22 Million ≈ $-48.84K |
-0.156x | +3.30% |
| 2021-12-31 | ILA143.82 Million ≈ $385.59K |
ILA-23.17 Million ≈ $-62.13K |
-0.161x | +10.07% |
| 2020-12-31 | ILA136.06 Million ≈ $364.77K |
ILA-24.38 Million ≈ $-65.36K |
-0.179x | -433.18% |
| 2019-12-31 | ILA99.87 Million ≈ $267.75K |
ILA-3.36 Million ≈ $-9.00K |
-0.034x | +99.79% |
| 2018-12-31 | ILA108.00K ≈ $289.54 |
ILA-1.76 Million ≈ $-4.71K |
-16.278x | -7635.02% |
| 2017-12-31 | ILA-492.00K ≈ $-1.32K |
ILA-106.29K ≈ $-284.95 |
0.216x | -- |
About Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd … Read more